Business Type:

Manufacturer

Year Established:

2018

No. of Employes:

200

Total Revenue:

US$10 Million - US$50 Million

Main Products:

(22-Dichlorocyclopropyl)benzene,(R)-(+)-9-(2-Hydroxypropyl)adenine

Address:

Hubei,China

Company Description

Welcome to Our Company

Our History
HUANGSHI FUERTAI as a main producer and supplier of tenofovir intermediates has been developing for more than 10 years, our main products such as DESMP, CMIC, RPC, HPA, PMPA, have a good presence in indian market and american market. The strong capacity, good quality and stable on-time supply ability make us the prior supplier for our end customers.
Our Factory
We have three factories, HUANGSHI FUERTAI CHEMICAL CO., LTD as parent company, HUANGSHI FUERTAI PHARMACEUTICAL TECH CO., LTD. as main production base for tenofovir inter mediates; HUBEI FUERJIA PHARMACEUTICAL CHEMICAL CO., LTD. as key input material production base. The parent company manage the business of other two factories.